IN 1964 Bloom reported 3 patients with metastatic renal cancer who responded favourably to hormone treatment with either progestogens or androgens. Subsequently other authors (Bloom, 1967;  Samuels, Sullivan and Howe, 1968;  Paine, Wright and Ellis, 1970) added further bormonal successes to the literature.
In the Rotterdamsch Radio-Therapeutisch Instituut it has been the rule to treat bone and soft tissue metastases of renal cancer with radiotherapy, to which they usually respond with regression and alleviation of pain. According to our experience haematogenous pulmonary metastases often remain stationary or regress, partially or completely; only exceptionally do they contribute to local distress or general deterioration. Therefore they were only occasionally treated by high-voltage irradiation. After the radio-therapeutic possibilities were exhausted, hormone treatment was applied in patients with extrapulmonary metastases according to the criteria discussed below; haematogenous pulmonary metastases in themselves were never a reason for staiting hormone treatment. (Table VI) . Jenkin (1967) 
